Gut germ boost: can a friendly bacteria supercharge Crohn's treatment?
NCT ID NCT07415473
Summary
This study is testing if adding a daily supplement of a specific gut bacteria, called Akkermansia muciniphila, to the standard Crohn's disease drug infliximab helps heal the intestinal lining better than the drug alone. About 400 adults with active Crohn's disease will be randomly assigned to receive either the combination or just the standard drug. The main goal is to see if more patients achieve complete healing of their intestinal ulcers after 26 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.